| Literature DB >> 32448301 |
Shiwei Gao1, Wanyun Ma1, Xinning Lyu1, Xiaolei Cao1, Yuxin Yao2.
Abstract
BACKGROUND: Melatonin can regulate plant growth, development and biotic responses by causing global changes in gene expression; however, the melatonin-induced changes in gene expression via the modification of DNA methylation remain unclear in plants.Entities:
Keywords: Disease resistance; Flavonoid biosynthesis; Grape berries; Melatonin; Methylome; Transcriptome
Mesh:
Substances:
Year: 2020 PMID: 32448301 PMCID: PMC7247213 DOI: 10.1186/s12870-020-02445-w
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Fig. 1Determination of berry veraison (a, b) and changes in melatonin content (c) in ‘Merlot’ berries under 50 μM melatonin treatment. Berry veraison was indicated by berry coloring, increases in total soluble solids and anthocyanins and decreases in titratable acid. Values represent the means ± SD of three replicates. * Significant difference, P < 0.05; ** highly significant difference, P < 0.01
Fig. 2Methylation levels of different chromosomes and genomic regions in ‘Merlot’ berries. a The outermost bold lines indicate different chromosomes and their lengths at a 50 kilobase resolution. Red, green, black and blue peak shape diagrams indicate the methylation levels of mC, mCG, mCHG and mCHH, respectively, at different chromosome sites, and the peak height indicates the methylation level. The second to fifth circles are from control berries, and the sixth to ninth circles are from melatonin-treated berries. b Changes in the levels of CG, CHG and CHH methylation in melatonin-treated berries compared to the control. TSS, transcription start site. TTS, transcription termination site. Up2K and Down2K represent the 2000 bp upstream of the TTS and downstream of the TTS, respectively. c Percentages of differentially methylated cytosines in different genomic regions
Fig. 3Analysis of the GO (a) and KEGG enrichment (b) of DMR-associated genes. P values are corrected to –log10 (P values) ranging from 0 to infinity, and a lower P value (i.e., a greater –log10 (P value)) indicates a higher intensity. The top 10 GO enrichments and the top 20 enriched KEGG pathways are displayed in this paper
Fig. 4Analysis of GO and KEGG enrichment of differentially expressed genes (DEGs) between the control and melatonin-treated ‘Merlot’ berries. a Differential transcript abundance between control and melatonin-treated berries. Red dots indicate differentially expressed genes. b GO clustering analysis of DEGs based on their functional enrichment. The top 10 GO enrichments are displayed. c KEGG enrichment analysis of DEGs. The top 10 enriched pathways are displayed. P values are corrected to –log10 (P values) ranging from 0 to infinity, and a lower P value (i.e., greater –log10 (P value)) indicates a higher intensity
Fig. 5Cross-sectional analysis of differentially methylated genes and DEGs and GO enrichment of the interconnected genes. a Cross-analysis was performed between the DMR-related genes and DEGs. Red dots represent negatively related genes, and blue dots represent positively related genes. The y-axis represents the differences in methylation levels (%). The x-axis represents the differences in gene expression. FC, fold change. b, c Validation of the results obtained from BS-Seq and RNA-Seq via methylation-specific PCR and qRT-PCR analyses of three selected loci. STS1, VIT_216s0100g01100; EDS1, VIT_217s0000g07370; CML41, VIT_218s0001g11830. Functional annotations of the above genes were listed in Table 1. FC (fold change) was calculated using the ratio of the expression in the treated berries to that in the control. d GO enrichment of the interconnected genes obtained through the comparison of DMP-related genes and DEGs. The top 10 enriched GO categories are displayed. P values are corrected to –log10 (P values) ranging from 0 to infinity, and a lower P value (i.e., greater –log10 (P value)) indicates a higher intensity
The most significantly altered genes in promoter methylation levels (|log2FC| > 2 or detected only in control berries) and expression levels (|log2FC| > 3 or detected only in melatonin-treated berries)
| Gene accession no | Position of DNA methylation | (log2FC) | Gene description | Gene function | |
|---|---|---|---|---|---|
| Methylation | Expression | ||||
| VIT_216s0039g01320 | chr16: 724,559–726,558 | − 2.06 | DT | Phenylalanine ammonia lyase 1 (PAL1) | Flavonoid biosynthesis |
| VIT_216s0100g01100 | chr16: 16,557,734–16,559,733 | −2.56 | 3.86 | Stilbene synthase 1 (STS1) | |
| VIT_200s0203g00220 | chrUn: 12,072,634–12,074,633 | DC | DT | G-type lectin s-receptor-like serine threonine-protein kinase | Immune response30 |
| VIT_212s0059g00160 | chr12: 5,071,913–5,073,912 | −6.64 | DT | Ankyrin repeat-containing protein (ACD6) | Disease resistance and antioxidation metabolism33 |
| VIT_217s0000g07370 | chr17: 8,237,664–8,239,663 | −5.64 | 4.86 | Enhanced disease susceptibility 1 (EDS1) | Plant-pathogen interaction42,43 |
| VIT_218s0001g11830 | chr18: 10,101,409–10,103,408 | −5.64 | 3.58 | probable calcium-binding protein CML41 | |
| VIT_204s0008g07140 | chr4: 7,279,720–7,281,719 | DC | 3.64 | Aspartic proteinase CDR1-like | Disease Resistance36 |
| VIT_216s0050g01150 | chr16: 18052767–18,054,766 | DC | 4.11 | Heat shock protein 83-like | |
| VIT_204s0044g01420 | chr4: 22,951,153–22,953,152 | −3.83 | 4.70 | Probable polygalacturonase-like | |
| VIT_210s0003g05450 | chr10: 10098885–10,100,884 | −4.32 | 3.41 | Reticuline oxidase-like protein | Response of plants to pathogenic attack 38 |
| VIT_219s0014g00470 | chr19: 478152–480,151 | −3.06 | 3.07 | Leucine-rich repeat receptor-like serine/threonine-protein kinase | MAMP-triggered innate immunity 38 |
| VIT_210s0003g01220 | chr10: 2,552,768–2,554,767 | −4.32 | 4.42 | Heavy metal-associated isoprenylated plant protein 26 | Plant responses to environmental changes35 |
| VIT_205s0077g01540 | chr5: 1240180–1,242,179 | −2.25 | 3.44 | Pathogenesis-related protein 10 | Response to biotic and abiotic stresses37 |
| VIT_204s0008g03530 | chr4: 2888437–2,890,436 | DC | 3.69 | Ankyrin repeat-containing protein | Unknown |
| VIT_203s0063g00550 | chr3: 4,059,484–4,061,483 | DC | 6.01 | Unnamed protein product | Unknown |
| VIT_218s0001g08500 | chr18: 6,946,257–6,948,256 | −2.40 | 3.51 | Unnamed protein product | Unknown |
| VIT_200s0270g00120 | chrUn: 19,991,241–19,993,240 | −4.32 | 4.59 | Kunitz-type trypsin inhibitor | Unknown |
DC detected only in control berries, DT detected only in melatonin-treated berries, FC fold change
Fig. 6Effects of melatonin and 5́-Aza on disease resistance, flavonoid accumulation, transcripts and DNA methylation of the genes involved in ‘Merlot’ and/or ‘Shine Muscat’ berries. a Mycelial growth on B. cinerea-inoculated ‘Merlot’ berries treated with or without melatonin and 5́-Aza. b Phenotypes of the control and treated ‘Shine Muscat’ berries with melatonin and 5́-Aza. Decayed berries were removed at 21 DAT. c The average decay rate of ‘Shine Muscat’ berries determined at 21 DAT. d Flavonoid content in ‘Merlot’ and detached ‘Shine Muscat’ berries at 3 DAT. ND, not detected. e, f Expression difference in ‘Merlot’ (e) and detached ‘Shine Muscat’ berries (f) at 3 DAT. FC (fold change) was calculated using the ratio of the expression in the treated berries to that in the control. PAL1, VIT_216s0039g01320; STS1, VIT_216s0100g01100; EDS1, VIT_217s0000g07370; CML41, VIT_218s0001g11830. Functional annotations of the above genes were listed in Table 1. g DNA methylation in ‘Shine Muscat’ berries at 3 DAT
Fig. 7Transcription capacity of the EDS1 promoter to drive GUS expression in the presence of melatonin and/or MET1. a Expression difference of the five selected genes in ‘Merlot’ berries at 48 HAT from RNA-Seq and qRT-PCR analyses. MET1, VIT_212s0035g01770; MET1B, VIT_212s0035g01755; SadMET, VIT_214s0006g02170; CMT2_1; VIT_216s0039g02470; CMT2_2, VIT_216s0039g02460. b Prediction of methylated cytosine in the EDS1 promoter (http://www.urogene.org/cgi-bin/methprimer2). O/E values indicate the ratio between the actual value and expected value of the CpG locus. The 800-bp region with a high CpG level indicated by the black box was used as the promoter of EDS1 (Peds) to produce the construct of Peds-35S miniGUS. c Histochemical analysis of the transcriptional capacity of Peds to drive GUS expression in grape calluses agroinfiltrated with different vector constructs: B1, control calluses; B2 and B4, Peds-35S miniGUS; B3, Peds-35S miniGUS and 35S::MET1; B5, Peds-35S miniGUS and 35S::MET1 with melatonin treatment; B6, Peds-35S miniGUS with melatonin treatment. d Gus activities of grape calluses infiltrated by Agrobacterium containing the B1-B6 constructs. e DNA methylation level of the EPS1 promoter, including endogenous DNA and DNA provided by Peds- 35S miniGUS, in calluses infiltrated by Agrobacterium containing the B4-B6 constructs